General discussion, page-11910

Hey @Greenwave17

I guess a survey to determine the market size of patients, within the 936 million people worldwide, that suffer from OSA and that use public transport for their daily commute, would be interesting? I suspect this sub-group within the TAM is still huge.

Additional positives that no one has mentioned here today;
Reducing the occurrence of OSA will also assist in reducing secondary health issues from within this 936 million cohort of OSA sufferers

> reduction in cardiovascular disease,
> reduction in cognitive impairments such as memory loss,
> poor concentration and judgment,
> depression and
> death or injury due to traffic accidents resulting from excessive daytime sleepiness.

The costs associated with OSA are substantial, relating to lost productivity, workplace and motor vehicle accidents.

Good luck @Greenwave17